Mr. Aselage joined BioMarin in July 2005 as Senior Vice President, Global Commercial Operations. Prior to joining BioMarin, Mr. Aselage held the position of Executive Vice President of Global Commercial Operations at Cell Therapeutics where he led efforts to streamline the company's United States and European commercial operations. Prior to Cell Therapeutics, Mr. Aselage served as Senior Vice President of North American Sales and Marketing for Genzyme Corporation following Genzyme's September 2003 acquisition of Sangstat Medical Corporation where he had worked since February 1999. While at Sangstat, Mr. Aselage restructured the company's sales, marketing and medical affairs groups and led the successful effort to make Thymoglobulin® the top selling product in its class. From 1996 through 1999, Mr. Aselage served as Director of Sales and Marketing at Advanced Tissue Sciences where he established the company's first sales and customer service groups. Earlier in his career, Mr. Aselage held a variety of sales and sales management positions at biotechnology and pharmaceutical companies including Rhone-Poulenc Rorer Pharmaceuticals (now Sanofi-Aventis), Genentech, Inc., and Bristol Laboratories. Mr. Aselage holds a Bachelor of Science degree in Biology from the University of Notre Dame. |